PULSE Registry: for Patients Receiving Lutetium (177Lu) Vipivotide Tetraxetan

Clinical trial NCT07484269 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07484269
Sponsor: Novartis Pharmaceuticals
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Metastatic Prostate Cancer

Start date: 2026-08-01
Primary completion: 2031-07-31
Enrollment: 753

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.